Objective
To seek capital appreciation through investment in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
Management group
Frostrow Capital
Launch date
23/06/1997
Domicile
United Kingdom
Fund manager
Josh Golomb, Geoffrey C. Hsu
Dividend frequency
Data Not Available
Wind-up provisions
An opportunity to vote on the continuation of the Company is given to shareholders every five years. The next such continuation vote will be held at the AGM to be held in 2025.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
320.04 372.11 959.00 1,017.36 -5.74 8 0.00 N/A 1.1 (31/03/2023)
Scroll

Dividends

Dividends declared in last 12 months

There have been no dividends in the last 12 months.

Performance (%)

Return type 1 year 3 years 5 years 10 years
Biotech Growth Trust Share price total return 10.7 -29.2 34.3 116.0
Biotechnology & Healthcare AIC sector Share price total return -3.1 -15.8 5.3 129.0
Scroll

Share structure

Number of shares
33,372,198

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 22,541 1,210,290 17,227,307 111,850,529
Average N/A 56,173 67,726 88,593
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.22 11.92 147.16 1,165.07
Average N/A 0.55 0.58 0.92
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB0000385517 BIOG GBX London Stock Exchange - MAIN
Chi-x Europe Limited
London Stock Exchange
Scroll

Top holdings

Data as at : 31/01/2024

Investment % of total assets
Amgen Inc 9.3
Biogen Inc 7.9
Regeneron Pharmaceuticals Inc 5.0
Vaxcyte Inc Ordinary Shares 4.7
Sarepta Therapeutics Inc 4.5
Ionis Pharmaceuticals Inc 4.3
argenx SE 3.9
Quantumpharm Inc (Xtalpi) - Pfd 3.3
Scholar Rock Holding Corp 3.3
Other Assets And Liabilities -4.3

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.